INS and type 2 diabetes mellitus: The loss of sensitivity to the hormone insulin in specific target cells, primarily adipocytes, hepatocytes, and myocytes, is an inherent pathologic feature of obesity and its associated metabolic diseases such as T2D, nonalcoholic fatty liver disease, hypertension, dyslipidemia, cardiovascular diseases, and even cancer.